Gauging the Risk of Dual Enrollment - Independent Data Integrator - Clinical RSVP Whitepaper

A look at the current landscape and how young companies can set the stage for product launch.

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Making early commercial data and analytics decisions for launch cen future-proof their data management.

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Topline results from the Phase III VERITAC-2 trial found that vepdegestrant provided a statistically significant and clinically meaningful improvement in progression-free survival in patients with ER+/HER2- advanced or metastatic breast cancer.

Experts weigh in on today’s life sciences leadership-development priorities critical to long-term success.